Valeria Grandinetti
Overview
Explore the profile of Valeria Grandinetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Santoro F, Casanova A, Simone S, Alfieri C, Falcone A, Dello Strologo A, et al.
Eur J Intern Med
. 2023 Aug;
119:71-77.
PMID: 37573220
Background: direct oral anticoagulants (DOACs) are an alternative to conventional antagonist of vitamin-K (AVK). However, immune suppressive drugs (ISDs) may interfere with DOACs pharmacokinetic. Aim Of This Study: evaluate safety...
2.
Busutti M, Baraldi O, Porcu C, Samele G, Campus A, Grandinetti V, et al.
Kidney Int Rep
. 2023 Aug;
8(8):1676-1679.
PMID: 37547522
No abstract available.
3.
De Giglio A, Grandinetti V, Aprile M, Borelli G, Campus A, Chiocchini A, et al.
Lung Cancer
. 2022 Nov;
174:91-96.
PMID: 36356493
Objectives: The combination of immune-checkpoint inhibitors (ICI) and platinum-pemetrexed chemotherapy (CT) in first-line setting improved survival outcomes of advanced non-small cell lung cancer (NSCLC) patients. Among the various adverse events,...
4.
Maritati F, Provenzano M, Lerario S, Corradetti V, Bini C, Busutti M, et al.
Front Immunol
. 2022 Aug;
13:878736.
PMID: 35958558
Systemic sclerosis (SSc) is an immune-mediated rheumatic disease characterized by vascular abnormalities, tissue fibrosis, and inflammation. Renal disease occurring in patients with SSc may have a variable clinicopathological picture. However,...
5.
Maritati F, Bini C, Cuna V, Tondolo F, Lerario S, Grandinetti V, et al.
J Inflamm Res
. 2022 Jun;
15:3095-3103.
PMID: 35642217
For a long time, ABO incompatible living donor kidney transplantation has been considered contraindicated, due to the presence of isohemagglutinins, natural antibodies reacting with non-self ABO antigens. However, as the...
6.
Busutti M, Cingolani A, Natali F, Mattiotti M, Grandinetti V, Baraldi O, et al.
J Nephrol
. 2022 Mar;
35(4):1275-1278.
PMID: 35286598
No abstract available.
7.
Pini A, Faggioli G, Pini R, Mauro R, Gallitto E, Mascoli C, et al.
Ann Vasc Surg
. 2022 Feb;
82:13-29.
PMID: 35108560
Background: Transplant renal artery stenosis (TRAS) following kidney transplantation is a possible cause of graft failure. This review aimed to summarize the evidence about physiopathology, diagnosis and early and late...
8.
Cianciolo G, Tondolo F, Barbuto S, Iacovella F, Zavatta G, Altieri P, et al.
Am J Nephrol
. 2021 Sep;
52(8):611-619.
PMID: 34518468
Introduction: Denosumab represents a realistic treatment option to increase bone mineral density in kidney transplant recipients (KTRs). It is still unknown how and at what extent posttransplantation bone disease and...
9.
Grandinetti V, Baraldi O, Comai G, Corradetti V, Aiello V, Bini C, et al.
G Ital Nefrol
. 2020 Feb;
37(1).
PMID: 32068360
Psoriasis is a common chronic inflammatory disease of the skin that is increasingly being considered as a systemic inflammatory disorder due to its association with cardiovascular, metabolic, pulmonary, renal, liver,...
10.
Baraldi O, Grandinetti V, Donati G, Comai G, Battaglino G, Cuna V, et al.
Cell Transplant
. 2015 Jul;
25(6):995-1005.
PMID: 26160700
Gammopathies, multiple myeloma, and amyloidosis are plasma dyscrasias characterized by clonal proliferation and immunoglobulin overproduction. Renal impairment is the most common and serious complication with an incidence of 20-30% patients...